Home Curetis

Curetis

In operation
IPO
A Molecular Diagnostics Company
Basic
Enterprise Profile

Basic Information

Curetis Focuses on Multiparameter Testing for Multiple Analytes in a Single Run, Offering Broad Detection of Pathogens and Resistance Genes for Various Diseases. Curetis integrates today’s molecular diagnostics laboratories into an instrument for detecting severe bacterial infections as the first target application. However, the universal platform will also allow for future expansion into other clinical application areas, presenting more market opportunities beyond infectious diseases.
Curetis
Stuttgart,Baden-Wurttemberg,Germany
15~50 people
January 01, 2007
contact@curetis.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design
Application Scenarios
Novel Coronavirus